Evogliptin Not Yet Recruiting Phase 4 Trials for Metabolic Bone Disorder / Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04706637A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin